Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
MF | GO:0030295 | protein kinase activator activity | 19/1646 | 80/17697 | 0.0001045 | 0.002832 | 0.00233 | 19 | RABC9 | |
MF | GO:0019887 | protein kinase regulator activity | 33/1646 | 180/17697 | 0.0001157 | 0.003058 | 0.002516 | 33 | RABC9 | |
MF | GO:0008081 | phosphoric diester hydrolase activity | 21/1646 | 94/17697 | 0.000119 | 0.003067 | 0.002523 | 21 | RABC9 | |
MF | GO:0016493 | C-C chemokine receptor activity | 9/1646 | 23/17697 | 0.0001244 | 0.003132 | 0.002576 | 9 | RABC9 | |
MF | GO:0042578 | phosphoric ester hydrolase activity | 56/1646 | 367/17697 | 0.0001484 | 0.003648 | 0.003001 | 56 | RABC9 | |
MF | GO:0008201 | heparin binding | 31/1646 | 169/17697 | 0.0001818 | 0.004369 | 0.003593 | 31 | RABC9 | |
MF | GO:0019902 | phosphatase binding | 33/1646 | 185/17697 | 0.0001979 | 0.004643 | 0.003819 | 33 | RABC9 | |
MF | GO:0008307 | structural constituent of muscle | 13/1646 | 46/17697 | 0.0002021 | 0.004643 | 0.003819 | 13 | RABC9 | |
MF | GO:0035326 | enhancer binding | 26/1646 | 133/17697 | 0.0002067 | 0.004648 | 0.003823 | 26 | RABC9 | |
MF | GO:0001158 | enhancer sequence-specific DNA binding | 24/1646 | 119/17697 | 0.0002185 | 0.004811 | 0.003958 | 24 | RABC9 | |
MF | GO:0004713 | protein tyrosine kinase activity | 26/1646 | 134/17697 | 0.0002341 | 0.00505 | 0.004154 | 26 | RABC9 | |
MF | GO:0008022 | protein C-terminus binding | 33/1646 | 187/17697 | 0.0002432 | 0.005142 | 0.00423 | 33 | RABC9 | |
MF | GO:0019209 | kinase activator activity | 19/1646 | 86/17697 | 0.0002871 | 0.005837 | 0.004801 | 19 | RABC9 | |
MF | GO:0005125 | cytokine activity | 37/1646 | 220/17697 | 0.0002872 | 0.005837 | 0.004801 | 37 | RABC9 | |
MF | GO:0035591 | signaling adaptor activity | 18/1646 | 80/17697 | 0.0003239 | 0.00646 | 0.005314 | 18 | RABC9 | |
MF | GO:0042605 | peptide antigen binding | 10/1646 | 31/17697 | 0.0003364 | 0.006585 | 0.005417 | 10 | RABC9 | |
MF | GO:0032036 | myosin heavy chain binding | 6/1646 | 12/17697 | 0.0003618 | 0.006606 | 0.005434 | 6 | RABC9 | |
MF | GO:0035325 | Toll-like receptor binding | 6/1646 | 12/17697 | 0.0003618 | 0.006606 | 0.005434 | 6 | RABC9 | |
MF | GO:0001618 | virus receptor activity | 17/1646 | 74/17697 | 0.0003625 | 0.006606 | 0.005434 | 17 | RABC9 | |
MF | GO:0104005 | hijacked molecular function | 17/1646 | 74/17697 | 0.0003625 | 0.006606 | 0.005434 | 17 | RABC9 | |
MF | GO:0017147 | Wnt-protein binding | 11/1646 | 37/17697 | 0.0003814 | 0.006833 | 0.005621 | 11 | RABC9 | |
MF | GO:0048365 | Rac GTPase binding | 16/1646 | 69/17697 | 0.0004782 | 0.008424 | 0.00693 | 16 | RABC9 | |
MF | GO:0030275 | LRR domain binding | 7/1646 | 17/17697 | 0.0004998 | 0.008661 | 0.007124 | 7 | RABC9 | |
MF | GO:0019843 | rRNA binding | 15/1646 | 63/17697 | 0.0005272 | 0.008988 | 0.007393 | 15 | RABC9 | |
MF | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 23/1646 | 119/17697 | 0.0005537 | 0.009291 | 0.007642 | 23 | RABC9 | |
MF | GO:0003785 | actin monomer binding | 9/1646 | 28/17697 | 0.0006857 | 0.01115 | 0.009173 | 9 | RABC9 | |
MF | GO:0004629 | phospholipase C activity | 9/1646 | 28/17697 | 0.0006857 | 0.01115 | 0.009173 | 9 | RABC9 | |
MF | GO:0009055 | electron transfer activity | 22/1646 | 114/17697 | 0.0007386 | 0.01183 | 0.00973 | 22 | RABC9 | |
MF | GO:0004715 | non-membrane spanning protein tyrosine kinase activity | 12/1646 | 46/17697 | 0.0007824 | 0.01234 | 0.01015 | 12 | RABC9 | |
MF | GO:0019838 | growth factor binding | 25/1646 | 137/17697 | 0.0007938 | 0.01234 | 0.01015 | 25 | RABC9 |